Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
amyotrophic lateral sclerosis
Biotech
Ferrer nabs European rights for ALS asset in €500M pact
Ferrer is paying 80 million euros upfront to jointly develop neurodegenerative disease candidate pridopidine in Europe with Dutch biotech Prilenia Tx.
Darren Incorvaia
Apr 28, 2025 2:40pm
Denali’s ALS drug comes up short in trial extension
Mar 6, 2025 8:20am
Voyager's ALS program delayed by search for alternative payload
Feb 11, 2025 10:27am
Hormone therapies help mice with ALS get better sleep: study
Jan 29, 2025 2:00pm
FDA lifts clinical hold on Amylyx ALS trial
Jan 21, 2025 10:35am
Lilly crafts deal with UK biotech for new ALS antibodies
Jan 9, 2025 10:55am
